Insiders Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 01:35:44 2026-03-06 pm EST			5-day change	1st Jan Change
238.73 ^USD	-0.38%		-3.85%	+15.42%

09:01am	Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment	MT
08:46am	Oil Shock Meets Job Shock

Insiders

Mar. 04	Coloplast Names New CEO	MT
Mar. 04	Coloplast A/S Announces CEO Changes	CI
Feb. 24	Artiva Biotherapeutics, Inc. Appoints Thad Huston as Principal Financial Officer and Principal Accounting Officer, Effective from February 18, 2026	CI
Feb. 19	Johnson & Johnson Insider Sold Shares Worth $21,767,827, According to a Recent SEC Filing	MT
Feb. 19	Johnson & Johnson Insider Sold Shares Worth $15,109,759, According to a Recent SEC Filing	MT
Feb. 17	Integra Lifesciences Holdings Corporation Announces Appointments of Executives	CI
Feb. 17	Cyclerion Therapeutics, Inc. Announces Formation of Clinical Advisory Board	CI
Feb. 13	Olympus Corporation Announces Change of Executive Officer, Effective April 1, 2026	CI
Feb. 12	Oryzon Genomics, S.A. Announces Chief Medical Officer For CNS Programs Changes	CI
Feb. 09	NervGen Pharma Corp. Appoints Adam Rogers as President, Effective February 9, 2026	CI
Feb. 09	Nervgen Pharma Corp. Appoints Adam Rogers as Chief Executive Officer, Effective February 9, 2026	CI
Feb. 05	IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer	CI
Feb. 04	Freshpet, Inc. Announces Appointment of Ana Lopez as Senior Vice President of Supply Chain, Effective February 2, 2026	CI
Feb. 03	Rigel Pharmaceuticals, Inc. Appoints Michael P. Miller as an Independent Director and Member of the Board of Directors' Compensation Committee, Effective February 1, 2026	CI
Feb. 02	STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026	CI
Jan. 29	Johnson & Johnson Insider Sold Shares Worth $22,122,893, According to a Recent SEC Filing	MT
Jan. 28	BioNTech SE Announces Appointment of Kylie Jimenez to the Management Board as Chief People Officer, Effective March 1, 2026	CI
Jan. 19	MediPharm Labs CEO David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO	MT
Jan. 19	Medipharm Labs Corp. Announces CEO Changes, Effective January 23, 2026	CI
Jan. 15	N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading -- Update	DJ
Jan. 15	N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading	DJ
Jan. 14	BD Appoints Shawn Bevec as Senior Vice President of Investor Relations, Effective January 20, 2026	CI
Jan. 12	Outset Medical, Inc. Announces Board Changes	CI
Jan. 09	PRESS DIGEST-Wall Street Journal - January 9	RE
Jan. 08	Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors	CI